Metastatic Sarcoma Withdrawn Phase 2 Trials for Docetaxel (DB01248)

Back to Metastatic Sarcoma

Also known as: Sarcoma metastatic / Metastatic sarcoma (disorder) / Sarcoma, metastatic (morphologic abnormality)

IndicationStatusPhase
DBCOND0047219 (Metastatic Sarcoma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04906876
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced SarcomasTreatment